Comparing Lanreotide vs Sandostatin LAR Depot

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Lanreotide	Sandostatin LAR Depot (octreotide)	Enter another drug to compare

Lanreotide

Sandostatin LAR Depot (octreotide)

Prescription only

Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin LAR Depot may also be used for purposes not listed in this medication guide.

More about Lanreotide

More about Sandostatin LAR Depot (octreotide)

Ratings & Reviews

Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.

Sandostatin LAR Depot has an average rating of 8.7 out of 10 from a total of 7 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 0% reported a negative effect.

View all 1 reviews

View all 7 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Lanreotide side effects

View all Sandostatin LAR Depot side effects

Drug Class

Somatostatin and somatostatin analogs

Somatostatin and somatostatin analogs

Generic Availability

Lower cost generic

Lower cost generic approved

Pricing and Coupons * Prices are without insurance

Quantity	0.5 mL
Strength	120 mg/0.5 mL
Per unit^*	$5,308.44 - $14,959.66
Cost^*	$2,654.22 - $7,479.83

View all Lanreotide prices

Quantity	1 powder for injection, extended release
Strength	10 mg
Per unit^*	$3,771.34
Cost^*	$3,771.34

View all Sandostatin LAR Depot prices

Get free Discount Card

Dosage Forms

Subcutaneous solution

Intramuscular powder for injection, extended release

Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

720 hours

1.5 hours

CSA Schedule ¹ View glossary of CSA terms

Not a controlled drug

Is not subject to the Controlled Substances Act.

Not a controlled drug

Is not subject to the Controlled Substances Act.

Pregnancy Category

Category C Risk cannot be ruled out

See the full pregnancy warnings document.

Category B No proven risk in humans

See the full pregnancy warnings document.

Drug Interactions

A total of 165 drugs are known to interact with Lanreotide:

4 major drug interactions (8 brand and generic names)
149 moderate drug interactions (488 brand and generic names)
12 minor drug interactions (24 brand and generic names)

A total of 167 drugs are known to interact with Sandostatin LAR Depot:

6 major drug interactions (12 brand and generic names)
149 moderate drug interactions (488 brand and generic names)
12 minor drug interactions (24 brand and generic names)

Alcohol/Food/Lifestyle Interactions

Lanreotide may affect the absorption of dietary nutrients and medications that you take by mouth... View more

Octreotide may affect the absorption of dietary nutrients and medications that you take by mouth... View more

Disease Interactions

First Approval Date

N/A

WADA Class View classifications

N/A

More Information

Patient Resources

Lanreotide uses

Professional Resources

N/A

¹ The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Comparing Lanreotide vs Sandostatin LAR Depot

See also:

Cabometyx

Afinitor

Lutathera

Cometriq

Somatuline Depot

Zortress

Lutetium lu 177 dotatate

Cabozantinib

Everolimus

Further information

Comparing Lanreotide vs Sandostatin LAR Depot

See also:

Further information

Compare Drugs